Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Landsec delivers upbeat outlook as FY profits meet forecasts

(Sharecast News) - Real estate investment trust Landsec met consensus forecasts with a small increase full-year profits, as the company reiterated confidence in its plans to reallocate capital away from offices in the coming years. For the year ended 31 March, EPRA earnings came in at £374m, only marginally higher than the £371m earned the year before, but more or less in line with the £373m market estimate.

Landsec said that like-for-like net rental income growth of 5.0% and lower overhead costs outweighed the impact from significant disposals early in year and a rise in finance costs.

Occupancy across the portfolio rose by 100 basis points on a LFL basis to 97.2% - its highest level in five years.

The value of the portfolio increased 9.2% over the period to £10.88bn. However, EPRA net tangible assets per share were 874p, up from 859p the year before but below the 890p estimate.

The dividend was lifted to 40.4p per share from 39.6p previously.

Landsec, whose portfolio is predominantly made up of Central London office assets and major retail destinations across the UK, announced in February that it plans to shift capital over the next two to five years from offices to residential "where the volatility in returns is lower".

Commenting on the portfolio rebalancing on Friday, chief executive Mark Allan said: "Our capital allocation decisions from here are about ensuring that the growth outlook for our portfolio in 3-5 years' time is as positive as it is for our current portfolio today.

"That is why we have set out a clear plan to increase investment in major retail by a further £1bn and establish a £2bn+ residential platform by 2030, to be funded by rotating £3bn of capital out of offices, non-core investments and low or non-yielding pre-development assets."

Shares were down 0.6% at 600p in early deals on Friday.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.